Should medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part IV: Estimating the risks and benefits of an early detection program
- 31 October 1995
- Vol. 46 (4) , 445-461
- https://doi.org/10.1016/s0090-4295(99)80255-6
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- A Critique of the Decision Analysis for Clinically Localized Prostate CancerJournal of Urology, 1994
- Screening for Prostate CancerPublished by American Medical Association (AMA) ,1994
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 MenJournal of Urology, 1994
- Results of Conservative Management of Clinically Localized Prostate CancerNew England Journal of Medicine, 1994
- Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examinationUrology, 1993
- Serum Prostate-Specific Antigen in a Community-Based Population of Healthy MenJAMA, 1993
- Influence of Capsular Penetration on Progression Following Radical Prostatectomy: A Study of 196 Cases with Long-Term FollowupJournal of Urology, 1993
- Estimates of Change in Chronic Disability and Institutional Incidence and Prevalence Rates in the U.S Elderly Population From the 1982, 1984, and 1989 National Long Term Care SurveyJournal of Gerontology, 1993
- A Decision Analysis of Alternative Treatment Strategies for Clinically Localized Prostate CancerPublished by American Medical Association (AMA) ,1993
- Sex or survival: trade-offs between quality and quantity of life.Journal of Clinical Oncology, 1991